KLK3 and prostate carcinoma: In the general population, a PSA level of 4 ng/mL is commonly used by urologists and in primary care settings, since this threshold was used in the Prostate Cancer Prevention Trial and REDUCE trial [20, 28]; however, the optimal threshold for biopsy in clinical practice is debatable and should take other clinical factors into consideration.